STOCK TITAN

Mark Jenkins to sell 12,750 shares of Carvana (CVNA) under Form 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Mark Jenkins filed a Form 144 reporting 12,750 shares of Common Stock to be sold via an exercise of stock options on 05/01/2026. The filing also lists recent 10b5-1 sales of 12,750 shares on 04/01/2026, 03/02/2026, and 02/02/2026 with gross proceeds shown.

The broker listed is Morgan Stanley Smith Barney LLC. The filing records cash proceeds for prior 10b5-1 sales of $3,956,931.20, $4,120,162.00, and $5,229,874.60.

Positive

  • None.

Negative

  • None.

Insights

Notice of proposed resale under Rule 144 with prior 10b5-1 executions recorded.

The filing lists a proposed sale of 12,750 shares via option exercise on 05/01/2026 and documents three prior 10b5-1 executions by Mark Jenkins in 02/2026, 03/2026, and 04/2026

These entries serve as a resale notice; cash flows and method are shown as cash and brokered through Morgan Stanley Smith Barney LLC. Timing and final execution depend on settlement mechanics and plan terms.

Shares proposed for sale 12,750 shares exercise of stock options on <date>05/01/2026</date>
10b5-1 sale proceeds (02/02/2026) $5,229,874.60 10b5-1 sale of 12,750 shares on <date>02/02/2026</date>
10b5-1 sale proceeds (03/02/2026) $4,120,162.00 10b5-1 sale of 12,750 shares on <date>03/02/2026</date>
10b5-1 sale proceeds (04/01/2026) $3,956,931.20 10b5-1 sale of 12,750 shares on <date>04/01/2026</date>
Broker Morgan Stanley Smith Barney LLC Listed on Form 144 cover information
Form 144 regulatory
"filed a Form 144 reporting 12,750 shares to be sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
10b5-1 regulatory
"10b5-1 Sales for MARK JENKINS listed for three prior dates"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Exercise of Stock Options financial
"Securities To Be Sold: Exercise of Stock Options on 05/01/2026"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Mark Jenkins' Form 144 for CVNA report?

It reports a proposed sale of 12,750 CVNA shares via an option exercise on 05/01/2026. The filing also lists prior 10b5-1 sales in 02/02/2026, 03/02/2026, and 04/01/2026.

How much cash did recent 10b5-1 sales generate according to the filing?

The filing shows gross proceeds of $5,229,874.60 on 02/02/2026, $4,120,162.00 on 03/02/2026, and $3,956,931.20 on 04/01/2026 for prior 10b5-1 trades.

Which broker is listed on the Form 144 for these CVNA shares?

The broker identified is Morgan Stanley Smith Barney LLC with an address at 1 New York Plaza, 8th Floor, New York, NY 10004, which is recorded on the Form 144 cover information.

Was the sale method and consideration specified in the filing?

Yes. The proposed transaction on 05/01/2026 is listed as an exercise of stock options with cash as the consideration method; prior executions are listed as 10b5-1 sales with gross cash proceeds.